Literature DB >> 2374405

Detection of fentanyl and its analogs by enzyme-linked immunosorbent assay.

W Ruangyuttikarn1, M Y Law, D E Rollins, D E Moody.   

Abstract

A prototype enzyme-linked immunosorbent assay (ELISA) for fentanyl, a potent synthetic narcotic analgesic, was used to detect the presence of fentanyl and its analogs in human urine. Human drug-free urine was spiked with 0.02 to 100 ng/mL of fentanyl or with 0.1 to 500 ng/mL of each analog and used as a sample in the ELISA. Sensitivity and precision of the assay were analyzed specifically for detection of fentanyl. Cross-reactivities of fentanyl and nine analogs, acetylfentanyl, p-methylfentanyl, p-fluorofentanyl, butyrylfentanyl, (+/-)trans-3-methylfentanyl, (+/-)cis-3-methylfentanyl, alpha-methylfentanyl, benzylfentanyl, and alfentanil for this assay were also determined. The results indicate that the ELISA was capable of detecting urinary fentanyl with a limit of detection of 0.25 ng/mL and a reasonable "working cutoff" of 0.5 ng/mL. The assay was moderately precise with within-run precision, determined at fentanyl concentrations of 10.0 and 2.5 ng/mL, showing coefficients of variation from 7.7 to 10.4% and between-run precision, determined at concentrations of 10.0 and 2.5 ng/mL, showing coefficients of variation from 14.2 to 23.7%. Acetylfentanyl, p-fluorofentanyl, p-methylfentanyl, and butyrylfentanyl show good cross-reactivity in the assay relative to fentanyl. The cross-reactivities equivalent to 2 ng/mL of fentanyl for acetylfentanyl, p-fluorofentanyl, p-methylfentanyl, and butyrylfentanyl were 111, 93, 87, and 77%, respectively. The (+/-)trans-3-methylfentanyl, alpha-methylfentanyl, and (+/-)cis-3-methylfentanyl show less cross-reactivity; their percent cross-reactivities equivalent to 2 ng/mL of fentanyl were 50, 19, and 3%, respectively. Benzylfentanyl and alfentanil, however, do not show any cross-reactivity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2374405     DOI: 10.1093/jat/14.3.160

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  7 in total

1.  Increase in Drug Overdose Deaths Involving Fentanyl-Rhode Island, January 2012-March 2014.

Authors:  Melissa C Mercado; Steven A Sumner; M Bridget Spelke; Michele K Bohm; David E Sugerman; Christina Stanley
Journal:  Pain Med       Date:  2018-03-01       Impact factor: 3.750

2.  Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs.

Authors:  Paul T Bremer; Atsushi Kimishima; Joel E Schlosburg; Bin Zhou; Karen C Collins; Kim D Janda
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-16       Impact factor: 15.336

3.  Application of the fentanyl analog screening kit toward the identification of emerging synthetic opioids in human plasma and urine by LC-QTOF.

Authors:  Logan C Krajewski; Kenneth D Swanson; William A Bragg; Rebecca L Shaner; Craig Seymour; Melissa D Carter; Elizabeth I Hamelin; Rudolph C Johnson
Journal:  Toxicol Lett       Date:  2019-12-05       Impact factor: 4.372

4.  ACMT Position Statement: Interpretation of Urine Opiate and Opioid Tests.

Authors:  Andrew Stolbach; Nicholas Connors; Lewis Nelson; Ken Kulig
Journal:  J Med Toxicol       Date:  2021-11-15

5.  A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose.

Authors:  Matthew K Griswold; Peter R Chai; Alex J Krotulski; Melissa Friscia; Brittany P Chapman; Neha Varma; Edward W Boyer; Barry K Logan; Kavita M Babu
Journal:  J Med Toxicol       Date:  2017-10-02

Review 6.  Misuse of Novel Synthetic Opioids: A Deadly New Trend.

Authors:  Matthew P Prekupec; Peter A Mansky; Michael H Baumann
Journal:  J Addict Med       Date:  2017 Jul/Aug       Impact factor: 3.702

7.  A GC-MS method for the determination of furanylfentanyl and ocfentanil in whole blood with full validation.

Authors:  Nektaria Misailidi; Sotiris Athanaselis; Panagiota Nikolaou; Maria Katselou; Yannis Dotsikas; Chara Spiliopoulou; Ioannis Papoutsis
Journal:  Forensic Toxicol       Date:  2018-10-22       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.